Next Article in Journal
Factors Regulating Fluid Restitution and Plasma Volume Reduction over the Course of Hemodialysis
Next Article in Special Issue
Xeomin®, a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury
Previous Article in Journal
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
Previous Article in Special Issue
Prediction Model for Identifying Computational Phenotypes of Children with Cerebral Palsy Needing Neurotoxin Treatments
 
 
Article

Article Versions Notes

Action Date Notes Link
article pdf uploaded. 30 December 2022 17:32 CET Version of Record https://www.mdpi.com/2072-6651/15/1/30/pdf-vor
article xml file uploaded 11 January 2023 08:35 CET Original file -
article xml uploaded. 11 January 2023 08:35 CET Update https://www.mdpi.com/2072-6651/15/1/30/xml
article pdf uploaded. 11 January 2023 08:35 CET Updated version of record https://www.mdpi.com/2072-6651/15/1/30/pdf
article html file updated 11 January 2023 08:36 CET Original file -
article html file updated 5 March 2023 02:04 CET Update https://www.mdpi.com/2072-6651/15/1/30/html
Back to TopTop